Brief: Scope Fluidics Unit Completes Stage Five Of Works On Bacteromic Project
April 9 (Reuters) - Scope Fluidics SA SCPP.WA :
* UNIT COMPLETES STAGE FIVE OF WORKS ON BACTEROMIC PROJECT
* SEES RISK OF COVID-19 IMPACT ON POSSIBLITY OF CONDUCTING
EXTERNAL TESTING FOR BACTEROMIC
* SAYS RISK COULD EXTEND PREVALIDATION TEST PERIOD
Source text for Eikon: ID:nEM3QQjVka
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys